Terms: = Uterine cancer AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE AND Prognosis
10 results:
1. Enhancing prognostic accuracy: a SEER-based analysis for overall and cancer-specific survival prediction in cervical adenocarcinoma patients.
Chen L; Chen Y; Shi H; Cai R
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17027-17037. PubMed ID: 37747524
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic values of human epididymis protein 4 expression in patients with endometrial cancer: A systematic review and meta-analysis.
Han LN; Han YW; Yan P
J Obstet Gynaecol Res; 2022 Sep; 48(9):2255-2269. PubMed ID: 35844088
[TBL] [Abstract] [Full Text] [Related]
3. Can the combination of DWI and T2WI radiomics improve the diagnostic efficiency of cervical squamous cell carcinoma?
Wang S; Jiang T; Hu X; Hu H; Zhou X; Wei Y; Mao X; Zhao Z
Magn Reson Imaging; 2022 Oct; 92():197-202. PubMed ID: 35842193
[TBL] [Abstract] [Full Text] [Related]
4. Pretreatment Squamous Cell Carcinoma Antigen (SCC-Ag) as a Predictive Factor for the Use of Consolidation Chemotherapy in Cervical cancer Patients After Postoperative Extended-Field Concurrent Chemoradiotherapy.
Zhang G; Miao L; Wu H; Zhang Y; Fu C
Technol Cancer Res Treat; 2021; 20():15330338211044626. PubMed ID: 34605696
[No Abstract] [Full Text] [Related]
5. Genetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and pβ-Cat675 are prognostic biomarkers of cervical cancer.
Scholl SM; Beal J; de Koning L; Girard E; Popovic M; de la Rochefordière A; Lecuru F; Fourchotte V; Ngo C; Floquet A; Berns EM; Kenter G; Gestraud P; von der Leyen H; Lecerf C; Puard V; Roman SR; Latouche A; Kereszt A; Balint B; Rouzier R; Kamal M
EBioMedicine; 2020 Nov; 61():103049. PubMed ID: 33096476
[TBL] [Abstract] [Full Text] [Related]
6. Clinical characteristics and risk of second primary lung cancer after cervical cancer: A population-based study.
Qian C; Liu H; Feng Y; Meng S; Wang D; Nie M; Xu M
PLoS One; 2020; 15(8):e0231807. PubMed ID: 32756555
[TBL] [Abstract] [Full Text] [Related]
7. The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas.
Zhan X; Li L; Wu M; Lang J
Arch Gynecol Obstet; 2019 Oct; 300(4):1045-1052. PubMed ID: 31520260
[TBL] [Abstract] [Full Text] [Related]
8. Role of
Albano D; Zizioli V; Treglia G; Odicino F; Giubbini R; Bertagna F
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(1):10-16. PubMed ID: 30396849
[TBL] [Abstract] [Full Text] [Related]
9. Use of Aggressive Surveillance for Locoregional Endometrial cancer After Local Therapy.
Yalamanchi P; Shabason JE; Zhang X; Ko EM; Lin LL
Int J Gynecol Cancer; 2018 Sep; 28(7):1264-1270. PubMed ID: 30036223
[TBL] [Abstract] [Full Text] [Related]
10. Analysis of clinicopathologic factors predicting para-aortic lymph node metastasis in endometrial cancer.
Nomura H; Aoki D; Suzuki N; Susumu N; Suzuki A; Tamada Y; Kataoka F; Higashiguchi A; Ezawa S; Nozawa S
Int J Gynecol Cancer; 2006; 16(2):799-804. PubMed ID: 16681764
[TBL] [Abstract] [Full Text] [Related]
